In our study, we showed that StAR and CYP11A1 did not display any significant circadian variations in glioma cells, whereas TSPO levels followed a circadian rhythm in vitro and in vivo (mouse brain lysates). The gene discussed is TSPO; the disease is central nervous system cancer.